24 Nov 2022 10:37
Β
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Β
Β
MyHealthChecked PLC
("MyHealthChecked" or the "Company")
Β
Director/PDMR Dealing
Β
MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer of the Company, purchased 125,000 Ordinary Shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.849p per Ordinary share (the "Purchase"). Following the Purchase, Nicholas Edwards has a beneficial interest of 125,000 Ordinary Shares, representing 0.016 per cent. of the total issued share capital.
Β
In addition, Lesley Innes, Non-Executive Director, purchased 250,000 Ordinary Shares of 0.1p each at a price of 1.835p per Ordinary Share. Following the Purchase, Lesley Innes has a beneficial interest of 250,000 Ordinary Shares, representing 0.032 per cent. of the total issued share capital.
Β
Β
For further information contact:
Β
MyHealthChecked plc | www.myhealthchecked.com | |
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
Nicholas Edwards, Chief Financial Officer | ||
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | mikeseabrook@oberoninvestments.com | |
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com | |
Anna Dunphy | Mob: +44(0)7876 741 001 | |
Β
Β
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
Β
Β
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests, supported by a user-friendly digital interface..
Β
MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.
Β
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Β
Β
NotificationΒ andΒ publicΒ disclosureΒ ofΒ transactionsΒ byΒ personsΒ dischargingΒ managerial responsibilitiesΒ andΒ personsΒ closelyΒ associatedΒ withΒ them
Β
Β
1 Β | Details of the person discharging managerial responsibilities/person closely associated Β | ||||
a) Β | Name Β Β | Nicholas Edwards | |||
2 Β | Reason for the notification Β | ||||
a) Β | Position/status Β Β | Chief Financial Officer | |||
b) Β | Initial notification/amendment Β Β | Initial Notification | |||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | ||||
a) Β | Name Β Β | MyHealthChecked PLC Β | |||
b) Β | LEI Β Β | 213800RBHY6LZDG13168 | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β Β | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary shares of 0.1p each | |||
Identification code | GB00BYZ2R301 | ||||
b) Β | Nature of the transaction Β Β | Purchase of Ordinary Shares | |||
c) Β | Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.849p | 125,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | N/A - Single transaction | ||||
- Price | |||||
e) Β | Date of the transaction Β Β | 24 November 2022 | |||
f) Β | Place of the transaction Β Β | AIM, London Stock Exchange (XLON) | |||
Β
1 Β | Details of the person discharging managerial responsibilities/person closely associated Β | ||||
a) Β | Name Β Β | Lesley Innes | |||
2 Β | Reason for the notification Β | ||||
a) Β | Position/status Β Β | Non-Executive Director | |||
b) Β | Initial notification/amendment Β Β | Initial Notification | |||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | ||||
a) Β | Name Β Β | MyHealthChecked PLC Β | |||
b) Β | LEI Β Β | 213800RBHY6LZDG13168 | |||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β Β | ||||
a) Β | Description of the financial instrument, type of instrument | Ordinary shares of 0.1p each | |||
Identification code | GB00BYZ2R301 | ||||
b) Β | Nature of the transaction Β Β | Purchase of Ordinary Shares | |||
c) Β | Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
1.835p | 250,000 | ||||
d) Β | Aggregated information | ||||
- Aggregated volume | N/A - Single transaction | ||||
- Price | |||||
e) Β | Date of the transaction Β Β | 24 November 2022 | |||
f) Β | Place of the transaction Β Β | AIM, London Stock Exchange (XLON) | |||
Β
Follow the stocks